Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: CP-751,871|DRUG: exemestane|DRUG: exemestane|DRUG: Fulvestrant
Sponsor: Pfizer